Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation Versus Standard Treatment in Patients With Recurrent Non-Obstructive Acute Cholangitis
NCT07509346Phase 2Not yet recruiting
- Sponsor
- Hospital Universitario Puerta de Hierro Majadahonda
- Start
- Jun 2026
- Primary completion
- May 2029
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in acute cholangitis, sponsored by Hospital Universitario Puerta de Hierro Majadahonda. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
acute cholangitis
Beyond the preview
Go deeper on NCT07509346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509346.